<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8809320</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1600</journal-id>
<journal-id journal-id-type="nlm-ta">Neuron</journal-id>
<journal-id journal-id-type="iso-abbrev">Neuron</journal-id>
<journal-title-group>
<journal-title>Neuron</journal-title>
</journal-title-group>
<issn pub-type="ppub">0896-6273</issn>
<issn pub-type="epub">1097-4199</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30826183</article-id>
<article-id pub-id-type="pmc">6472967</article-id>
<article-id pub-id-type="doi">10.1016/j.neuron.2019.02.002</article-id>
<article-id pub-id-type="manuscript">NIHMS1520957</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Distinct modes of presynaptic inhibition of cutaneous afferents and their functions in behavior</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zimmerman</surname>
<given-names>Amanda L.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kovatsis</surname>
<given-names>Eleni M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Poszgai</surname>
<given-names>Riana Y.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tasnim</surname>
<given-names>Aniqa</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Qiyu</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ginty</surname>
<given-names>David D.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Neurobiology, Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115</aff>
<aff id="A2"><label>2</label>Lead Contact</aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1">AUTHOR CONTRIBUTIONS</p>
<p id="P2">A.L.Z. and D.D.G. conceived the study; A.L.Z. performed all electrophysiology experiments; A.L.Z., E.M.K., and R.P. performed genetic manipulations and histological and behavioral experiments; A.T. generated and characterized the GABRB3 antibody; Q.Z. contributed to the analysis of VGlut3 interneurons and qPCR; A.L.Z. developed software and analyzed data; A.L.Z. and D.D.G. wrote the paper with editing from E.M.K. and input from all authors.</p>
</fn>
<corresp id="CR1"><label>*</label>correspondence: <email>david_ginty@hms.harvard.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P92">DECLARATION OF INTERESTS</p>
<p id="P93">The authors declare no competing interests.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>7</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>27</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<day>17</day>
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>17</day>
<month>4</month>
<year>2020</year>
</pub-date>
<volume>102</volume>
<issue>2</issue>
<fpage>420</fpage>
<lpage>434.e8</lpage>
<!--elocation-id from pubmed: 10.1016/j.neuron.2019.02.002-->
<abstract id="ABS1">
<title>SUMMARY</title>
<p id="P3">Presynaptic inhibition (PSI) of primary sensory neurons is implicated in controlling gain and acuity in sensory systems. Here, we define circuit mechanisms and functions of PSI of cutaneous somatosensory neuron inputs to the spinal cord. We observed that PSI can be evoked by different sensory neuron populations and mediated through at least two distinct dorsal horn circuit mechanisms. Low-threshold cutaneous afferents evoke a GABA<sub>A</sub>-receptor dependent form of PSI that inhibits similar afferent subtypes, whereas small-diameter afferents predominantly evoke an NMDA-receptor dependent form of PSI that inhibits large diameter fibers. Behaviorally, loss of either GABA<sub>A</sub>Rs or NMDARs in primary afferents leads to tactile hypersensitivity across skin types, while loss of GABA<sub>A</sub>Rs but not NMDARs leads to impaired texture discrimination. Post-weaning age loss of either GABA<sub>A</sub>Rs or NMDARs in somatosensory neurons causes systemic behavioral abnormalities, revealing critical roles of two distinct modes of PSI of somatosensory afferents in adolescence and throughout adulthood.</p>
</abstract>
<abstract abstract-type="summary" id="ABS2">
<title>ETOC</title>
<p id="P4">Zimmerman et al. define distinct neurotransmitter and circuit mechanisms that gate the flow of tactile sensory information from the periphery into the spinal cord and characterize their roles in tactile sensitivity and behaviors</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>